CLOBETASOL PROPIONATE

Clobetasol Propionate Adverse Events Reported to the FDA Over Time

How are Clobetasol Propionate adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Clobetasol Propionate, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Clobetasol Propionate is flagged as the suspect drug causing the adverse event.

Most Common Clobetasol Propionate Adverse Events Reported to the FDA

What are the most common Clobetasol Propionate adverse events reported to the FDA?

Drug Ineffective	69 (3.28%)
Incorrect Drug Administration Durat...	47 (2.24%)
Product Quality Issue	42 (2%)
Off Label Use	38 (1.81%)
Headache	27 (1.28%)
Burning Sensation	24 (1.14%)
Erythema	24 (1.14%)
Pruritus	24 (1.14%)
Condition Aggravated	22 (1.05%)
Skin Atrophy	22 (1.05%)
Blood Cortisol Decreased	21 (1%)
	Show More
Cushingoid	20 (.95%)
Necrotising Fasciitis	18 (.86%)
Overdose	16 (.76%)
Rash	16 (.76%)
Application Site Pain	15 (.71%)
Drug Administration Error	15 (.71%)
Vomiting	15 (.71%)
Weight Increased	15 (.71%)
Adrenal Insufficiency	14 (.67%)
Hypertension	14 (.67%)
Alopecia	13 (.62%)
Dyspnoea	13 (.62%)
Oedema Peripheral	13 (.62%)
Psoriasis	13 (.62%)
Blister	12 (.57%)
Cellulitis	12 (.57%)
Hypersensitivity	12 (.57%)
Squamous Cell Carcinoma	12 (.57%)
Diabetes Mellitus	11 (.52%)
Glaucoma	11 (.52%)
Growth Retardation	11 (.52%)
Inappropriate Schedule Of Drug Admi...	11 (.52%)
Pain	11 (.52%)
Skin Discolouration	11 (.52%)
Adrenal Suppression	10 (.48%)
Asthenia	10 (.48%)
Drug Exposure During Pregnancy	10 (.48%)
Dry Skin	10 (.48%)
Hair Disorder	10 (.48%)
Malaise	10 (.48%)
Medication Error	10 (.48%)
Accidental Exposure	9 (.43%)
Dizziness	9 (.43%)
Drug Dispensing Error	9 (.43%)
Hypotension	9 (.43%)
Pain In Extremity	9 (.43%)
Skin Disorder	9 (.43%)
Cataract	8 (.38%)
Drug Dependence	8 (.38%)
Ecchymosis	8 (.38%)
Obesity	8 (.38%)
Pyrexia	8 (.38%)
Telangiectasia	8 (.38%)
Application Site Erythema	7 (.33%)
Chest Pain	7 (.33%)
Convulsion	7 (.33%)
Drug Eruption	7 (.33%)
Dysgeusia	7 (.33%)
Lymphopenia	7 (.33%)
Skin Striae	7 (.33%)
Swelling Face	7 (.33%)
Abortion Induced	6 (.29%)
Application Site Pruritus	6 (.29%)
Blepharitis	6 (.29%)
Blood Corticotrophin Decreased	6 (.29%)
Blood Pressure Increased	6 (.29%)
Cerebrovascular Accident	6 (.29%)
Decreased Appetite	6 (.29%)
Dermatitis	6 (.29%)
Diarrhoea	6 (.29%)
Expired Drug Administered	6 (.29%)
Haemoglobin Decreased	6 (.29%)
Increased Appetite	6 (.29%)
Muscle Twitching	6 (.29%)
Muscular Weakness	6 (.29%)
Neck Pain	6 (.29%)
Peptic Ulcer Perforation	6 (.29%)
Peritonitis	6 (.29%)
Platelet Count Increased	6 (.29%)
Pregnancy	6 (.29%)
Scar	6 (.29%)
Skin Exfoliation	6 (.29%)
Skin Infection	6 (.29%)
Skin Irritation	6 (.29%)
Wound Dehiscence	6 (.29%)
Atrophy	5 (.24%)
Blood Glucose Increased	5 (.24%)
Caustic Injury	5 (.24%)
Chorioretinopathy	5 (.24%)
Death	5 (.24%)
Drug Administered At Inappropriate ...	5 (.24%)
Erysipelas	5 (.24%)
Fall	5 (.24%)
Gangrene	5 (.24%)
Hair Colour Changes	5 (.24%)
Hepatic Enzyme Increased	5 (.24%)
Hypercholesterolaemia	5 (.24%)
Hypertrichosis	5 (.24%)
Ill-defined Disorder	5 (.24%)
Incorrect Dose Administered	5 (.24%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Clobetasol Propionate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Clobetasol Propionate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Clobetasol Propionate

What are the most common Clobetasol Propionate adverse events reported to the FDA?

Epidermal And Dermal Conditions	217 (10.32%)
Medication Errors	148 (7.04%)
Therapeutic And Nontherapeutic Effe...	87 (4.14%)
Neurological	72 (3.43%)
Infections - Pathogen Unspecified	68 (3.24%)
Skin Appendage Conditions	57 (2.71%)
Adrenal Gland	53 (2.52%)
Administration Site Reactions	46 (2.19%)
Bacterial Infectious	46 (2.19%)
Product Quality Issues	45 (2.14%)
Musculoskeletal And Connective Tiss...	41 (1.95%)
	Show More
Therapeutic Procedures And Supporti...	39 (1.86%)
Headaches	34 (1.62%)
Cornification And Dystrophic Skin	33 (1.57%)
Endocrine Investigations	31 (1.47%)
Appetite And General Nutritional	30 (1.43%)
Gastrointestinal Signs	29 (1.38%)
Respiratory	28 (1.33%)
Muscle	26 (1.24%)
Skin Vascular Abnormalities	24 (1.14%)
Physical Examination Topics	23 (1.09%)
Injuries	22 (1.05%)
Vascular Hypertensive	22 (1.05%)
Vision	22 (1.05%)
Chemical Injury And Poisoning	20 (.95%)
Allergic Conditions	19 (.9%)
Ocular Infections, Irritations And ...	18 (.86%)
Cardiac And Vascular Investigations	17 (.81%)
Hepatobiliary	17 (.81%)
Glucose Metabolism Disorders	16 (.76%)
Hematology Investigations	16 (.76%)
Decreased And Nonspecific Blood Pre...	15 (.71%)
Procedural And Device Related Injur...	15 (.71%)
Psychiatric	15 (.71%)
Hepatic And Hepatobiliary	14 (.67%)
Miscellaneous And Site Unspecified ...	14 (.67%)
White Blood Cell	14 (.67%)
Cranial Nerve Disorders	13 (.62%)
Gastrointestinal Motility And Defec...	13 (.62%)
Glaucoma And Ocular Hypertension	12 (.57%)
Lifestyle Issues	12 (.57%)
Body Temperature Conditions	11 (.52%)
Fungal Infectious	11 (.52%)
Lipid Metabolism	11 (.52%)
Metabolic, Nutritional And Blood Ga...	11 (.52%)
Obstetric And Gynecological Therape...	11 (.52%)
Anxiety Disorders	10 (.48%)
Central Nervous System Vascular	10 (.48%)
Movement Disorders	10 (.48%)
Ocular Structural Change, Deposit A...	10 (.48%)
Skin And Subcutaneous Tissue	10 (.48%)
Vascular	10 (.48%)
Pregnancy, Labour, Delivery And Pos...	9 (.43%)
Tissue	9 (.43%)
Urinary Tract Signs	9 (.43%)
Anterior Eye Structural Change, Dep...	8 (.38%)
Cardiac And Vascular Disorders Cong...	8 (.38%)
Joint	8 (.38%)
Lipid Analyses	8 (.38%)
Upper Respiratory Tract Disorders	8 (.38%)
Eye	7 (.33%)
Gastrointestinal Ulceration And Per...	7 (.33%)
Injuries By Physical Agents	7 (.33%)
Mood Disorders	7 (.33%)
Neurological, Special Senses And Ps...	7 (.33%)
Seizures	7 (.33%)
Viral Infectious	7 (.33%)
Vulvovaginal Disorders	7 (.33%)
Angiedema And Urticaria	6 (.29%)
Bone Disorders	6 (.29%)
Dental And Gingival Conditions	6 (.29%)
Ocular Neuromuscular	6 (.29%)
Peritoneal And Retroperitoneal Cond...	6 (.29%)
Renal Disorders	6 (.29%)
Cardiac Arrhythmias	5 (.24%)
Cutaneous Neoplasms Benign	5 (.24%)
Electrolyte And Fluid Balance Condi...	5 (.24%)
Fatal Outcomes	5 (.24%)
Hypothalamus And Pituitary Gland	5 (.24%)
Menstrual Cycle And Uterine Bleedin...	5 (.24%)
Neurological Disorders Of The Eye	5 (.24%)
Pigmentation	5 (.24%)
Vascular Hemorrhagic	5 (.24%)
Gastrointestinal Hemorrhages	4 (.19%)
Investigations, Imaging And Histopa...	4 (.19%)
Neuromuscular	4 (.19%)
Oral Soft Tissue Conditions	4 (.19%)
Penile And Scrotal Disorders	4 (.19%)
Renal And Urinary Tract Investigati...	4 (.19%)
Sleep Disorders	4 (.19%)
Sleep Disturbances	4 (.19%)
Spleen, Lymphatic And Reticulendoth...	4 (.19%)
Thyroid Gland	4 (.19%)
Toxicology And Therapeutic Drug Mon...	4 (.19%)
Bone And Joint Injuries	3 (.14%)
Bronchial Disorders	3 (.14%)
Gastrointestinal Conditions	3 (.14%)
Gastrointestinal Inflammatory Condi...	3 (.14%)
Musculoskeletal And Connective Tiss...	3 (.14%)
Myocardial	3 (.14%)
Sexual Function And Fertility	3 (.14%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Clobetasol Propionate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Clobetasol Propionate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.